Interested? It’s the topic of an online symposium planned for 9-11 March 2021. Details on the IPK website.

Agricultural Biodiversity Weblog
Agrobiodiversity is crops, livestock, foodways, microbes, pollinators, wild relatives …
Interested? It’s the topic of an online symposium planned for 9-11 March 2021. Details on the IPK website.

The Biodiversity Information System for Europe is a partnership between the European Commission and the European Environment Agency. It seems to have recently updated its website. Or at least that’s the impression I got from a recent tweet, so I checked it out. There’s no search function on the site, but some rapid browsing could not turn up any references to genebanks or agricultural biodiversity. So I googled “genebanks in:biodiversity.europa.eu” and I got a hit on a page that is no longer on the site. WayBackMachine turns up a 2016 version with some basic information on genetic resources for food and agriculture, including genebanks, that seems to have disappeared in the interim. Maybe the Biodiversity Information System for Europe has decided to focus on in situ conservation only? It seems a pity, if true.
You may remember an old blog post of mine over on the work website describing how an impasse over access and benefit sharing arrangements relating to “digital sequence information” (DSI) on plant genetic resources scuppered the most recent round of Plant Treaty negotiations. 1 No? Well, this is how I put it at the time:
Some countries, and many civil society organizations, contended … that seed companies would soon be able to produce and market new varieties simply by manipulating genomic data in open-access repositories. That is, without needing to access actual seeds, and thus triggering the ABS provisions of the Treaty. In their view, this is a loophole that should be closed.
Others said that this is far-fetched, and that DNA sequence data needs to be freely available for researchers and breeders to do their work properly, and deliver new, better varieties, faster. Charging scientists for using genomic data, even if a way could be found of doing it, would impede vital research.
I was a bit worried about the binary at the time. It was an easy — though maybe a bit lazy — way to summarize the situation, but surely there was room for nuance? That was brought home to me by a recent paper from the project Wissenschaftliche Lösungsansätze für Digitale Sequenzinformation (Scientific approaches for digital sequence information) from the German Federal Ministry of Education and Research.
In past DSI discussions, a stark contrast has often been presented: either the status quo with an open-access model and extensive non-monetary benefit-sharing but zero monetary benefit-sharing OR a closed-access system with monetary benefit-sharing but dramatically reduced or zero non-monetary benefit-sharing and a loss of open-access. We are convinced that the debate between open access and monetary benefit-sharing is a false choice and that both principles can thrive if innovative ideas and open-mindedness are brought to the table.
And the paper is actually a great contribution to the cause of finding a workable middle way. It’s worth reading the whole thing, or at least the executive summary, but basically, it suggests 5 options:
I particularly like the micro-levy idea.
Do any data jockeys on here care to share their thoughts?